178 related articles for article (PubMed ID: 30406361)
1. Phase I/IIa PET imaging study with
Joraku A; Hatano K; Kawai K; Kandori S; Kojima T; Fukumitsu N; Isobe T; Mori Y; Sakata M; Hara T; Nasu K; Minami M; Iizumi Y; Nishiyama H
Ann Nucl Med; 2019 Feb; 33(2):119-127. PubMed ID: 30406361
[TBL] [Abstract][Full Text] [Related]
2. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
Pandit-Taskar N; O'Donoghue JA; Ruan S; Lyashchenko SK; Carrasquillo JA; Heller G; Martinez DF; Cheal SM; Lewis JS; Fleisher M; Keppler JS; Reiter RE; Wu AM; Weber WA; Scher HI; Larson SM; Morris MJ
J Nucl Med; 2016 Dec; 57(12):1858-1864. PubMed ID: 27516450
[TBL] [Abstract][Full Text] [Related]
3. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of the diagnostic utility of
Vlachostergios PJ; Niaz MJ; Thomas C; Christos PJ; Osborne JR; Margolis DJA; Khani F; Bander NH; Scherr DS; Tagawa ST
Prostate; 2022 Mar; 82(4):483-492. PubMed ID: 34985786
[TBL] [Abstract][Full Text] [Related]
5. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
6. First-in-Humans Imaging with
Pandit-Taskar N; Postow MA; Hellmann MD; Harding JJ; Barker CA; O'Donoghue JA; Ziolkowska M; Ruan S; Lyashchenko SK; Tsai F; Farwell M; Mitchell TC; Korn R; Le W; Lewis JS; Weber WA; Behera D; Wilson I; Gordon M; Wu AM; Wolchok JD
J Nucl Med; 2020 Apr; 61(4):512-519. PubMed ID: 31586002
[TBL] [Abstract][Full Text] [Related]
7. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
Pandit-Taskar N; O'Donoghue JA; Beylergil V; Lyashchenko S; Ruan S; Solomon SB; Durack JC; Carrasquillo JA; Lefkowitz RA; Gonen M; Lewis JS; Holland JP; Cheal SM; Reuter VE; Osborne JR; Loda MF; Smith-Jones PM; Weber WA; Bander NH; Scher HI; Morris MJ; Larson SM
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2093-105. PubMed ID: 25143071
[TBL] [Abstract][Full Text] [Related]
8. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
[TBL] [Abstract][Full Text] [Related]
9.
Schwenck J; Sonanini D; Seyfried D; Ehrlichmann W; Kienzle G; Reischl G; Krezer P; Wilson I; Korn R; Gonzalez-Menendez I; Quintanilla-Martinez L; Seith F; Forschner A; Eigentler T; Zender L; Röcken M; Pichler BJ; Flatz L; Kneilling M; la Fougere C
Theranostics; 2023; 13(8):2408-2423. PubMed ID: 37215571
[No Abstract] [Full Text] [Related]
10. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
11. First-in-human imaging with [
Tendler S; Dunphy MP; Agee M; O'Donoghue J; Aly RG; Choudhury NJ; Kesner A; Kirov A; Mauguen A; Baine MK; Schoder H; Weber WA; Rekhtman N; Lyashchenko SK; Bodei L; Morris MJ; Lewis JS; Rudin CM; Poirier JT
medRxiv; 2024 Jan; ():. PubMed ID: 38260492
[TBL] [Abstract][Full Text] [Related]
12. ⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
Mendler CT; Gehring T; Wester HJ; Schwaiger M; Skerra A
J Nucl Med; 2015 Jul; 56(7):1112-8. PubMed ID: 25999431
[TBL] [Abstract][Full Text] [Related]
13. [
Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Biodistribution of a [
O'Donoghue JA; Danila DC; Pandit-Taskar N; Beylergil V; Cheal SM; Fleming SE; Fox JJ; Ruan S; Zanzonico PB; Ragupathi G; Lyashchenko SK; Williams SP; Scher HI; Fine BM; Humm JL; Larson SM; Morris MJ; Carrasquillo JA
Mol Pharm; 2019 Jul; 16(7):3083-3090. PubMed ID: 31117485
[TBL] [Abstract][Full Text] [Related]
15. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using
Ulaner GA; Lyashchenko SK; Riedl C; Ruan S; Zanzonico PB; Lake D; Jhaveri K; Zeglis B; Lewis JS; O'Donoghue JA
J Nucl Med; 2018 Jun; 59(6):900-906. PubMed ID: 29146695
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.
Knowles SM; Zettlitz KA; Tavaré R; Rochefort MM; Salazar FB; Stout DB; Yazaki PJ; Reiter RE; Wu AM
J Nucl Med; 2014 Mar; 55(3):452-9. PubMed ID: 24504052
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.
Seo JW; Mahakian LM; Tam S; Qin S; Ingham ES; Meares CF; Ferrara KW
Nucl Med Biol; 2015 Feb; 42(2):155-63. PubMed ID: 25451215
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.
Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753
[TBL] [Abstract][Full Text] [Related]
19. Phase I study to assess safety, biodistribution and radiation dosimetry for
Merkx RIJ; Lobeek D; Konijnenberg M; Jiménez-Franco LD; Kluge A; Oosterwijk E; Mulders PFA; Rijpkema M
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3277-3285. PubMed ID: 33651116
[TBL] [Abstract][Full Text] [Related]
20. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
